130
Participants
Start Date
December 13, 2024
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2028
TUB-030
A complete treatment cycle is defined as 21 calendar days. TUB-030 will be administered as an intravenous (IV) solution on day 1 of each treatment cycle
RECRUITING
Mount Sinai, New York
RECRUITING
University of Miami, Miami
RECRUITING
Ohio State University, Columbus
RECRUITING
Cleveland Clinic, Cleveland
RECRUITING
Mayo Clinic, Rochester
RECRUITING
Washington University, St Louis
RECRUITING
NEXT Oncology - Dallas, Irving
RECRUITING
NEXT Oncology - San Antonio, San Antonio
RECRUITING
NEXT Oncology Austin, Austin
RECRUITING
Fred Hutchinson Cancer Center, Seattle
RECRUITING
Yale Cancer Center, New Haven
RECRUITING
Dana Farber Cancer Institute, Boston
RECRUITING
Princess Margaret, Toronto
Tubulis GmbH
INDUSTRY